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• Building a Robot Scientist forces us to make concrete engineering decisions 
involving the relation between abstract and physical objects, and between 
observed and theoretical phenomena, as well as the ways hypotheses are 
created. 
• Some scientific problems are so complex they require a vast amount of 
research, and there are simply not enough human scientists to do it all; 
automation offers our best hope for solving those problems. We can address 
this problem  using robot scientists to combine rapidly developing 
technologies for both laboratory automation and data analysis.
We have so far built and validated two Robot Scientists: Adam – a high throughput 
system capable of analysing thousands of yeast strains – and more recently, Eve – a 
system designed to test drug or siRNA libraries against a small number of yeast 
strains [1]. 
Why Develop Robot Scientists?
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Standard assay: 
Compounds are added to assay plates via non-contact 
acoustic transfer. Yeast stocks are manually added to 
Eve’s reagent dispensers and then equal volumes are 
added to each well. Eve’s robot arms and linear 
actuators are used to transfer plates and other 
consumables within the system. Each plate is bar-
coded, and all movements are recorded.
Assay plates are stored in a shaking incubator, and 
fluorescence or absorption is measured every 90 
minutes using one of Eve’s two microplate readers. Eve 
also has an automated microscope capable of taking 
both bright-field and fluorescence images across a 
broad range of wavelengths. 
Eve’s Equipment
DARPA Big Mechanism: Big mechanisms are large, explanatory models of 
complicated systems in which interactions have important causal effects. Using 
cancer pathways as a test case, the Big Mechanism program aims to develop 
technology to read research abstracts and papers to extract pieces of causal 
mechanisms, assemble these pieces into more complete causal models, and reason 
through and test these models to provide explanations.  Eve’s role is to test and 
further develop the hypotheses produced as part of this project.
CHIST-ERA An Adaptive Automated Scientific Laboratory (ADALAB): This 
project aims to develop a framework for semi-automated and automated knowledge 
discovery by teams of human and robot scientists. The framework will integrate and 
advance a number of ICT methodologies: knowledge representation, ontology 
engineering, semantic technologies, machine learning, bioinformatics, and automated 
experimentation (Robot Scientists). The AdaLab framework will be evaluated using 
the diauxic shift – a yeast pathway with biomedical relevance to cancer and ageing.
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Eve’s Methodology
Phase 1: Mass-screening
Eve mass-screens a subset of its library to find “hit” 
compounds for the assay. This subset is currently 
chosen randomly, but could be selected using 
structural information about the target protein.
Phase 3: Automated QSAR analysis & intelligent 
library screening
Using confirmed hits Eve executes cycles of machine 
learning that hypothesize QSARs, and tests them on 
new compounds. Eve currently lacks access to 
chemical synthesis automation, and therefore screens 
untested compounds from its library rather than 
synthesise new chemicals. 
Phase 2: Hit-confirmation
Eve re-assays hit compounds using multiple repeats 
and titrations to eliminate false positives. Eve’s 
integration of screening and hit-confirmation is 
similar to advanced screening systems that execute 
a high-throughput screen followed by high-content 
screening for selected compounds.
This graph displays data simulating a screen of the 
Maybridge Hitfinder library against Plasmodium vivax
DHFR. The differential utility of intelligent screening is 
shown in blue. It is cost-optimal to screen between a 
third and a half of Eve’s small library, with a larger 
library the screened proportion would be expected to 
be smaller.
A Robot Scientist uses techniques from the field of artificial intelligence to carry out 
cycles of experimentation on a laboratory robotic system. It automatically generates 
hypotheses from background knowledge and models, designs physical experiments 
to test these hypotheses, carries out the experiments on a laboratory robotic system, 
and then analyses and interprets the results. 
Improved data capture records:
• Goals, hypotheses, results, conclusions
• Direct experimental data
• Meta-data such as environmental conditions, detailed experiment content layout 
information, and instrument settings, protocols and runtime logs. These meta-data 
can be especially important when studying complex biological systems where the 
specifics of the environment can have such a large effect on results.
Scan this QR code to see footage of Eve in action on the BBC website!
The modular nature of Eve’s equipment allows use of a range of experimental formats. 
Intelligent screening yields increased hit rates:
In a simulation run of Eve’s process of QSAR learning/testing from a compound 
library, we can see a clear increase in intelligent screening hit rates (red) compared 
to a standard brute-force approach (black). 
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Dihydrofolate reductase (DHFR) catalyses the reduction of 
dihydrofolate to tetrahydrofolate, an important step in the use 
of folates for purine synthesis. DHFR inhibitors are routinely 
used as prophylactics against malaria, but are no longer used 
as a standard treatment due to drug resistance. 
TNP-470 is an angiogenesis inhibitor derived from the 
antimicrobial compound fumagillin, which has also been 
investigated as an anti-cancer drug. TNP-470 has binds to P. 
falciparum MetAP2 in vitro and inhibits growth of 
P. falciparum strains, as well as lowering parasitemia in mice 
[4]. 
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Eve’s results indicate that TNP-470 has high activity against P. 
vivax DHFR: the hit-confirmation curve displayed here shows 
an impact on P. vivax (blue), but not human (red) or P. 
falciparum (green) versions of the enzyme. 
Enzyme inhibition assays demonstrated that P. vivax DHFR is 
1000-fold more sensitive to TNP-470 than its human 
counterpart [5]. This is consistent with the results of Eve’s 
assays and suggests that our approach identified a bona fide 
DHFR inhibitor with improved selectivity.
Validation of Eve focused on neglected tropical diseases including malaria, Chagas
disease, leishmaniasis, schistosomiasis and African sleeping sickness [2]
• These diseases infect hundreds of millions of people, and annually kill 
millions of people.
• The cause of these diseases is clear, and they can be treated simply by 
killing the parasites causing them. These criteria are not met for many 
diseases targeted by the pharmaceutical industry.
• There is little competition from the pharmaceutical industry.
Plasmodium vivax is the most frequently occurring and widely distributed of the 
protozoal parasites that cause malaria, with at least 80 million infections occurring 
annually [3]. P. vivax cannot be continuously cultured in laboratory conditions, and 
the two main treatments, chloroquine and primaquine, have been in use for over 60 
years. 
Case Study: Identifying TNP-470 as a Malaria Treatment
Benefits of Intelligent Screening
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